Lam Research stock: $25 billion buyback reshapes weekly focus

Published on 11/07/2026 at 11:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lam Research stock enters a new capital-return phase after a busy week. Shareholder votes also reinforced governance continuity at the chip-equipment maker.

Key developments for investors

Shareholders elected Lam Research's 10 director nominees and approved executive compensation at the November 3 annual meeting.
The board's new capital-return authorization adds flexibility but does not oblige Lam Research to repurchase shares.
Component availability, clean-room capacity and China exposure remain important factors for the semiconductor equipment outlook.

Lam Research, US5128073062, Illustration mit AI erstellt.

Lam Research stock enters the weekend after a week shaped by shareholder decisions and a major capital-return announcement. At 11:05 CET on Saturday, November 7, the stock traded at EUR 180.51 on Lang & Schwarz.

Capital return takes center stage

On November 5, Lam Research announced that its board had approved a USD 25 billion share repurchase authorization and declared a quarterly dividend of USD 0.33 per share. The announcement was carried by Financial Times.

The authorization supplements remaining balances from an earlier program. Lam Research said purchases may occur through open-market or private transactions, but the program has no termination date and does not require the company to buy any shares. The dividend is scheduled for payment on January 6, 2027, to shareholders of record on December 2, 2026.

Shareholders back board proposals

At the annual meeting on November 3, shareholders elected all 10 director nominees, approved named executive officer compensation on an advisory basis and ratified KPMG as the fiscal 2027 auditor. A proposal concerning the right to call special shareholder meetings was not approved, according to the SEC filing.

The voting outcome supports continuity as Lam Research manages strong semiconductor-equipment demand alongside supply constraints. Management has highlighted limits involving components and clean-room capacity, while China-related exposure remains a separate risk for future shipments and regional revenue.

Investors can follow the real-time quote of Lam Research stock.

The broader US market backdrop remains relevant for chip-equipment shares; current developments can be followed in the S&P 500 market coverage.

More company-specific developments are available in more news and analyses on Lam Research stock.